Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
30.87
-0.18 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
31.04
+0.17 (0.55%)
After-hours: Dec 5, 2025, 5:13 PM EST
Stoke Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 40.57 | -88.98 | -104.7 | -101.07 | -85.81 | -52.24 | |
| Depreciation & Amortization | 1.89 | 2.18 | 2.47 | 1.55 | 0.97 | 0.89 | |
| Loss (Gain) From Sale of Assets | -0.01 | - | 0 | - | 0.03 | 0 | |
| Loss (Gain) From Sale of Investments | -1.36 | -1.64 | -0.33 | -0.21 | 0.14 | - | |
| Stock-Based Compensation | 29.53 | 27.47 | 25.26 | 22.85 | 16.45 | 5.77 | |
| Other Operating Activities | 2.34 | 2.27 | 2.26 | 1.99 | 1.26 | 1.04 | |
| Change in Accounts Payable | 14.57 | 3.09 | -3.21 | -3.53 | 2.9 | 5.2 | |
| Change in Unearned Revenue | -25.58 | -29.39 | -3.35 | 51.74 | - | - | |
| Change in Other Net Operating Assets | -2.56 | -1.84 | 0.53 | -5.18 | -2.85 | -2.88 | |
| Operating Cash Flow | 52.85 | -86.85 | -81.07 | -31.87 | -66.91 | -42.22 | |
| Capital Expenditures | -0.48 | -0.2 | -1.62 | -3.96 | -1.2 | -1.05 | |
| Investment in Securities | -124.45 | -107.27 | 107.56 | -41.92 | -75.23 | - | |
| Investing Cash Flow | -124.93 | -107.48 | 105.95 | -45.88 | -76.43 | -1.05 | |
| Issuance of Common Stock | 5.62 | 131.09 | 53.01 | 46.41 | 1.29 | 108.59 | |
| Other Financing Activities | - | - | - | 0 | -0 | -0.49 | |
| Financing Cash Flow | 5.62 | 131.09 | 53.01 | 46.41 | 1.28 | 108.11 | |
| Net Cash Flow | -66.47 | -63.23 | 77.89 | -31.34 | -142.05 | 64.84 | |
| Free Cash Flow | 52.37 | -87.05 | -82.68 | -35.83 | -68.11 | -43.27 | |
| Free Cash Flow Margin | 25.47% | -238.15% | -941.72% | -288.82% | - | - | |
| Free Cash Flow Per Share | 0.88 | -1.61 | -1.88 | -0.92 | -1.85 | -1.29 | |
| Levered Free Cash Flow | 29.57 | -26.45 | -45.07 | -36.15 | -34.78 | -24.35 | |
| Unlevered Free Cash Flow | 29.57 | -26.45 | -45.07 | -36.15 | -34.78 | -24.35 | |
| Change in Working Capital | -20.81 | -28.14 | -6.03 | 43.02 | 0.05 | 2.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.